Researchers at the Donald W. Reynolds Institute on Aging at the University of Arkansas for Medical Sciences (UAMS) gave an Alzheimer's patient an injection of a compound called perispinal etanercept and noticed a "dramatic and unprecedented therapeutic effect" within minutes of the injection.
"It is unprecedented that we can see cognitive and behavioral improvement in a patient with established dementia within minutes of therapeutic intervention," said [Sue Griffin, Ph.D., director of research at the Donald W. Reynolds Institute on Aging at the University of Arkansas for Medical Sciences (UAMS)]. "It is imperative that the medical and scientific communities immediately undertake to further investigate and characterize the physiologic mechanisms involved. This gives all of us in Alzheimer's research a tremendous new clue about new avenues of research, which is so exciting and so needed in the field of Alzheimer's. Even though this report predominantly discusses a single patient, it is of significant scientific interest because of the potential insight it may give into the processes involved in the brain dysfunction of Alzheimer's."